Vertebral Fusion Clinical Trial
Official title:
"Randomized Evaluation of Bone Ingrowth After Intervertebral Body Fusion With Either MectaLIF® PEEK or MectaLIF® TiPEEK Oblique"
| Verified date | February 2017 |
| Source | Johann Wolfgang Goethe University Hospital |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Clinical outcome with regard to oswestry disability index and lumbar fusion rate after implantation of titanium coated PEEK cage and common PEEK cage
| Status | Completed |
| Enrollment | 40 |
| Est. completion date | December 1, 2013 |
| Est. primary completion date | September 1, 2013 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Persistence of - low back pain, - sciatica and - spinal claudication after conservative treatment attributed to L3 to L5 lumbar segments. Exclusion Criteria: - previous lumbar spinal surgery - body mass index >35 kg/m² |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Mohammad ARAB MOTLAGH |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Clinical outcome assessed by Oswestry Disability Index (ODI) after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | Oswestry Disability Index (ODI) after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | 12 months | |
| Secondary | Fusion result | Fusion rate after instrumented transforaminal lumbar fusion with TiPEEK or common PEEK | 12 months |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06367933 -
Mini-invasive Spine Surgery for Neuromuscolar Scoliosis
|
N/A |